Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neramexane as preemptive and add-on analgesic in postoperative pain
2004-001782-18Phase 2Completed
- Sponsor
- Merz
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of neramexane in postoperative pain (3 arms), sponsored by Merz. Primary endpoint: Total opioid consumption in first 24 hours. Started Feb 2005; status: completed.
02
Drugs
neramexane
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2004-001782-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001782-18.